Possible mechanism of CCL2-induced Akt activation in prostate cancer cells

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3109-3113

  Mizutani, Kosuke ^a   Roca, Hernan ^a   Varsos, Zachary ^b   Pienta, Kenneth J ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Adenylyl cyclase; CCR2; ERK and Rho ROCK; G protein; Pertussis toxin

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; CHEMOKINE RECEPTOR CCR2; CHOLERA TOXIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PERTUSSIS TOXIN; PROTEIN KINASE B;

ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CARCINOGENESIS; CELL STRAIN PC 3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENYLATE CYCLASE; ADJUVANTS, IMMUNOLOGIC; BLOTTING, WESTERN; CHEMOKINE CCL2; CHOLERA TOXIN; HUMANS; MALE; PERTUSSIS TOXIN; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SINCALIDE; TUMOR CELLS, CULTURED;

EID: 68549083509     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cancer Facts and Figures. American Cancer Society, 2008 (http://www.cancer.org/docroot/stt/stt-0.asp?from=fast).
2. Isaacs JT: New strategies for the medical treatment of prostate cancer. BJU Int 96(Suppl 2): 35-40, 2005. (Pubitemid 43041975)
3. Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274, 2007.
4. Assinder SJ, Dong Q, Kovacevic Z et al: The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. Biochem J 417: 411-421, 2009.
5. New DC, Wu K, Kwok AW et al: G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis. FEBS J 274: 6025-6036, 2007. (Pubitemid 350135324)
6. Majumder PK and Sellers WR: Akt-regulated pathways in prostate cancer. Oncogene 24: 7465-7474, 2005.
7. Roca H, Varsos Z and Pienta KJ: CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 283: 25057-25073, 2008.
8. Loberg RD, Ying C, Craig M et al: Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 67: 9417-9424, 2007. (Pubitemid 47535932)
9. New DC and Wong YH: CC chemokine receptor-coupled signalling pathways. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35: 779-788, 2003.
10. Craig MJ and Loberg RD: CCL2 (monocyte chemoattractant protein-1) in cancer bone metastases. Cancer Metastasis Rev 25: 611-619, 2006.
11. Lu Y, Cai Z, Xiao G et al: CCR2 expression correlates with prostate cancer progression. J Cell Biochem 101: 676-685, 2007. (Pubitemid 46698852)
12. Loberg RD, Day LL, Harwood J et al: CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia 8: 578-586, 2006. (Pubitemid 44061313)
13. Thelen M: Dancing to the tune of chemokines. Nat Immunol 2: 129-134, 2001.
14. Schwindinger WF and Robishaw JD: Heterotrimeric G-protein βγ-dimers in growth and differentiation. Oncogene 20: 1653-1660, 2001.
15. Fields TA and Casey PJ: Signaling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321: 561-571, 1997.
16. Milligan G and Kostenis E: Heterotrimeric G-proteins: a short history. Br J Pharmacol 147: S46-55, 2006.
17. Myers SJ, Wong LM and Charo IF: Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J Biol Chem 270: 5786-5792, 1995.
18. Kleibeuker W, Jurado-Pueyo M, Murga C et al: Physiological changes in GRK2 regulate CCL2-induced signaling to ERK1/2 and Akt but not to MEK1/2 and calcium. J Neurochem 104: 979-992, 2008. (Pubitemid 351143638)
19. Merighi S, Benini A, Mirandola P et al: Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor. Purinergic Signal 2: 627-632, 2006. (Pubitemid 44848674)
20. Somlyo AP and Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2000.
21. Mizuno N and Itoh H: Functions and regulatory mechanisms of Gq-signaling pathways. Neurosignals 17: 42-54, 2009.
22. Kuang Y, Wu Y, Jiang H and Wu D: Selective G protein coupling by C-C chemokine receptors. J Biol Chem 271: 3975-3978, 1996. (Pubitemid 26074142)